A cikin sabuwar ci gaban kimiyya, masu bincike sun sami kyakkyawar shaida na yuwuwar ivermectin a cikin kula da COVID-19. Wani bincike da aka buga a wata babbar mujallar kiwon lafiya ya bayyana cewa ivermectin, maganin da aka saba amfani da shi don magance cututtuka na parasitic, na iya samun magungunan kashe kwayoyin cuta wanda zai iya yin tasiri a kan coronavirus. Wannan binciken ya zo ne a matsayin hasken bege a ci gaba da yakar cutar, yayin da ake ci gaba da neman magunguna masu inganci.
Bayyana Gaskiya:IvermectinTasirin Kimiyya da Labaran Lafiya:
Binciken, wanda ƙungiyar masu bincike daga mashahuran cibiyoyi suka gudanar, ya ƙunshi tsauraran gwaje-gwaje na maganin ivermectin a cikin dakin gwaje-gwaje. Sakamakon ya nuna cewa ivermectin ya iya hana kwafin kwayar cutar SARS-CoV-2, kwayar da ke da alhakin COVID-19. Wannan yana nuna cewa za a iya sake dawo da ivermectin azaman magani ga COVID-19, yana ba da zaɓi da ake buƙata sosai ga marasa lafiya da masu ba da lafiya.
Yayin da binciken ke da alƙawarin, masana sun yi gargaɗin cewa ana buƙatar ƙarin gwaje-gwaje na asibiti don cikakken fahimtar tasiri da amincin ivermectin a cikin kula da COVID-19. Masu binciken sun jaddada mahimmancin gudanar da gwaje-gwaje masu girma, bazuwar gwaji don tabbatar da binciken farko da kuma tantance mafi kyawun sashi da tsarin kulawa ga marasa lafiya na COVID-19.
Dangane da karuwar sha'awar ivermectin a matsayin yuwuwar jiyya ta COVID-19, hukumomin kiwon lafiya da hukumomin gudanarwa suna sa ido sosai kan abubuwan da ke faruwa. Hukumar Lafiya ta Duniya (WHO) ta amince da bukatar karin shaida kan amfani da ivermectin a cikin maganin COVID-19 kuma ta yi kira da a kara yin bincike don fayyace rawar da take takawa. A halin da ake ciki, Hukumar Abinci da Magunguna ta Amurka (FDA) ta bukaci yin taka tsantsan, tare da jaddada cewa ba a amince da ivermectin don rigakafi ko maganin COVID-19 ba.
Yayin da duniya ke ci gaba da kokawa da kalubalen da annobar ta haifar, yuwuwar ivermectin a matsayin magani ga COVID-19 yana ba da kyakkyawan fata. Tare da ci gaba da bincike da gwaje-gwaje na asibiti, al'ummar kimiyya suna aiki tuƙuru don gano duk hanyoyin da za a iya magance cutar. Sabbin binciken da aka yi akan kaddarorin antiviral na ivermectin suna ba da dalili mai gamsarwa na fata da kuma ƙarfafa mahimmancin binciken kimiyya mai ƙarfi a cikin neman ingantattun jiyya don COVID-19.
Lokacin aikawa: Yuli-30-2024
